Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone effects on muscle strength and mobility in ANCA-associated vasculitis
NL-OMON24482Not yet recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Sep 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of prednisolone in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV), sponsored by University Medical Center Groningen. Primary endpoints: Strength of knee extension and hip flexion, Mobility and 1 more. Planned start Sep 2015; status: not yet recruiting.
02
Drugs
prednisolone
03
Conditions
anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV)
Beyond the preview
Go deeper on NL-OMON24482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24482.